Acumen Pharmaceuticals Inc (ABOS)
2.95
-0.03
(-1.01%)
USD |
NASDAQ |
May 31, 16:00
2.95
0.00 (0.00%)
After-Hours: 20:00
Acumen Pharmaceuticals Cash from Investing (Quarterly): -9.203M for March 31, 2024
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | -9.203M |
| December 31, 2023 | -48.81M |
| September 30, 2023 | -92.00M |
| June 30, 2023 | 11.06M |
| March 31, 2023 | -41.93M |
| December 31, 2022 | -20.42M |
| September 30, 2022 | 55.92M |
| June 30, 2022 | 8.785M |
| Date | Value |
|---|---|
| March 31, 2022 | -5.099M |
| December 31, 2021 | -10.01M |
| September 30, 2021 | -94.10M |
| June 30, 2021 | -0.006M |
| March 31, 2021 | 0.00 |
| December 31, 2020 | 0.00 |
| September 30, 2020 | 0.00 |
| June 30, 2020 | 0.00 |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-94.10M
Minimum
Sep 2021
55.92M
Maximum
Sep 2022
-15.36M
Average
-2.552M
Median
Cash from Investing (Quarterly) Benchmarks
| Accuray Inc | -0.795M |
| Kezar Life Sciences Inc | 20.41M |
| NovaBay Pharmaceuticals Inc | 1.068M |
| Palatin Technologies Inc | 0.00 |
| iBio Inc | 1.00M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -17.86M |
| Cash from Financing (Quarterly) | 7.107M |
| Free Cash Flow | -50.78M |
| Free Cash Flow Per Share (Quarterly) | -0.2988 |
| Free Cash Flow Yield | -32.31% |